Table 4:
Study | n = | Study Type |
Type of pancreatectomy |
Endocrine Insufficiency |
Exocrine Insufficiency |
---|---|---|---|---|---|
Cherif et al.5 | 118 | Prospective, controlled cohort |
PD = 28 DP = 27 PSP = 63 |
6 (21.4%) 1 (3.7%) 3 (4.8%) |
16 (57.1%) 2 (7.4%) 2 (3.2%) |
Falconi et al.6 | 135 | Prospective, controlled cohort |
PD = 51 DP = 50 AR = 34 |
9 (17.6%) 7 (14.0%) 1 (2.9%) |
17 (33.3%) 9 (18.0%) 0 (0%) |
Lim et al.13 | 227 | Prospective, case series |
PD = 159 DP = 63 Enucleation = 5 |
28/178 without pre- operative endocrine insufficiency (15.7%) |
94/214 without pre- operative exocrine insufficiency (43.9%) |
Halloran et al.16 | 40 | Prospective, cohort |
PD = 37 DP = 3 |
- | 30/39 at 6 weeks (76.9%) 19/22 at 1 year (86.4%) |
Hirata et al.18 | 167 | Retrospective, cohort |
PD = 100 DP = 67 |
68 (40.7%) | - |
Kwon et al.21 | 229 | Retrospective, cohort |
PD = 94 DP = 118 CP = 17 |
52 (22.7%) | - |
Wu et al.33 | 3914 | Retrospective, population based |
PD = 3914 | 632 (16.1%) | - |
Ferrara et al.34 | 564 | Retrospective, cohort |
PD = 564 | 22 (3.9%) | - |
Orfanidis et al.35 | 41 | Retrospective, cohort (prospective interviews) |
PD = 41 | 8 (19.5%) | 5 (12.2%) |
Elliott et al.36 | 1165 | Retrospective, population based |
PD = 692 DP = 473 |
274/678 without pre- operative endocrine insufficiency (40.4%) |
235/678 without pre- operative endocrine insufficiency (34.7%) |
PD – pancreaticoduodenectomy, DP– distal pancreatectomy, PSP – pancreas sparing pancreatectomy (enucleation and central pancreatectomy), CP – central pancreatectomy, AR – atypical resection